Allegion plc

(New York Stock Exchange)
Bullish +55

Allegion stock reports 12.7 percent Q2 revenue growth

πŸ“ˆ Allegion reported Q2 revenue of $1.15 billion, marking a 12.7% year-over-year increase driven by strong Americas demand.

πŸ’° Adjusted EPS reached $2.40, beating the consensus estimate of $2.22 and reflecting 17.6% growth compared to the prior year.

🌎 Americas organic revenue grew 8.9% due to robust activity in education, healthcare, government, hospitality, and retail sectors.

πŸ“‰ International organic revenue contracted 1.2% despite a reported segment increase of 16.2%, highlighting regional operational challenges.

🏒 Acquisitions contributed 5.1% to total company sales, supporting overall top-line growth alongside organic expansion.

🎯 Management guided fiscal 2026 adjusted EPS between $8.85 and $9.00, providing a clear outlook for future performance.

πŸ“Š Nine brokerages maintain a Hold consensus with an average price target of $162.50, implying modest upside potential.

πŸ’Ή The stock trades at $154.21 with a market cap of $13.1 billion, sitting within its 52-week range of $125 to $183.

Bullish Signals
  • Allegion delivered Q2 revenue of $1.15 billion, up 12.7% year over year, demonstrating strong top-line momentum.
  • Adjusted EPS of $2.40 exceeded analyst expectations of $2.22, showcasing the company's ability to beat consensus estimates.
  • Americas organic revenue grew 8.9%, driven by diverse demand across education, healthcare, government, and retail sectors.
  • Acquisitions added 5.1% to sales, indicating a successful strategy of expanding market presence through M&A.
  • Management provided clear fiscal 2026 guidance for adjusted EPS between $8.85 and $9.00, signaling confidence in future earnings.
Risk Factors
  • International organic revenue fell 1.2% year over year, indicating weakness outside the Americas region.
  • European demand remains a counter-factor to overall growth, creating a geographic imbalance in performance.
  • Enterprise resource planning disruption is cited as a material issue affecting international operations and segment results.
Full Analysis
Allegion plc reported robust second-quarter financial results, with revenue reaching $1.15 billion, representing a 12.7% year-over-year increase. The company's adjusted earnings per share (EPS) grew to $2.40, surpassing analyst consensus estimates of $2.22, while diluted GAAP EPS rose to $2.15 from the prior year's $1.85. This performance highlights a clear divergence in global operations, driven primarily by strong demand within the Americas region. The growth trajectory is heavily anchored in the Americas, where organic revenue expanded 8.9% fueled by increased activity across key sectors including education, healthcare, government, hospitality, and retail. Acquisitions contributed an additional 5.1% to total sales during the quarter. Conversely, international operations faced headwinds with organic revenue declining 1.2%, despite a reported segment growth of 16.2%, suggesting underlying challenges in European markets and potential disruptions related to enterprise resource planning systems. Market sentiment remains cautiously optimistic as nine brokerages maintain a Hold consensus rating with an average 12-month price target of $162.50, which sits approximately 5.4% above the stock's trading price of $154.21. Management has provided fiscal 2026 adjusted EPS guidance ranging between $8.85 and $9.00. With a market capitalization of $13.1 billion, Allegion continues to navigate a landscape where regional strength must offset international weakness to sustain long-term momentum.